Therapeutic agent for tumor

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8921333
SERIAL NO

13498771

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a therapeutic agent for a tumor, particularly a therapeutic agent for drug-resistant cancer, an agent for suppression or prophylaxis of tumor metastasis, and an agent for suppression or prophylaxis of cancer recurrence, containing a nucleic acid containing miR27b or a nucleotide having a nucleotide sequence having an identity of 70% or more with the nucleotide sequence shown by SEQ ID NO: 1 and having a function equivalent to miR27b.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ASAHI KASEI PHARMA CORPORATION1-1-2 YURAKUCHO CHIYODA-KU TOKYO 1000006 ?1000006
NATIONAL CANCER CENTER1-1 TSUKIJI 5-CHOME CHUO-KU TOKYO 1040045 ?1040045

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ochiya, Takahiro Tokyo, JP 86 233
Takahashi, Ryou-u Tokyo, JP 2 13

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 30, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00